Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)

Nycomed

Status: Completed

Conditions: Non-Erosive Reflux Disease; Erosive Gastroesophageal Reflux Disease

Treatments: Drug: Pantoprazole

Study type: Observational

Funder types: Industry

Identifiers

NCT00562094

PAN 20/40 PULS 07/10

Details and patient eligibility

About

The aim of the study was to evaluate the effect of Pantoprazole 20 mg/40 mg for 14 days on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) with special focus on the reduction of symptomatic sleep disorders.

Enrollment: 8,616 patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Main inclusion criteria:

• GERD
• NERD

Main exclusion criteria:

• Criteria as defined in the Summary of Product Characteristics

Trial design

8,616 participants in 1 patient group

Pantoprazole

Treatment:

Drug: Pantoprazole